Asian man wearing CPAP mask, connecting to air hose, sleeping on his bed in his bedroom with large window, good for sleep apnea story Patients and doctors are disagreeing about sleep apnea ...

The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

Here’s a closer look at GLP-1 drugs like Ozempic, Mounjaro, and Zepbound for sleep apnea, including how obesity is related to sleep apnea and how these medications might help.

Since then, Zepbound, the brand name for tirzepatide, has nearly become a household drug brand. Lilly estimates 4.5 million people take one of the Indianapolis drugmaker's GLP-1 medicines to lose ...

In December, GLP-1 agonist tirzepatide (Zepbound) became the first drug approved to treat moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity after two trials showed it reduced ...

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S. The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain ...

Zepbound’s 12.5 mg and 15 mg vials will be available July 7 for $499/month via LillyDirect. In trials, 36.2% of adults on 15 mg lost 25% or more of their body weight. A new wave of value and ...

Last week, Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, ... GLP-1 Zepbound is approved as first drug for sleep apnea. Dec 23, 2024.

But Zepbound is only for people with obesity and sleep apnea, the AASM noted. Also, Zepbound can reduce the severity of sleep apnea through weight loss but might not cure the problem.